Mode
Text Size
Log in / Sign up

Retrospective analysis of Systemic Inflammatory Response Index in elderly influenza A pneumonia

Retrospective analysis of Systemic Inflammatory Response Index in elderly influenza A pneumonia
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
Key Takeaway
Recognize the absence of numerical outcomes in this retrospective SIRI analysis of elderly influenza patients.

The study design was a retrospective analysis conducted at the China Resources Wuhan Iron and Steel General Hospital. The population included 160 patients aged 65 years or older diagnosed with influenza A virus pneumonia. This setting represents a single center experience rather than a broad multi institution cohort. The sample size of 160 subjects provides a moderate basis for observation but limits generalizability.

The primary exposure assessed was the Systemic Inflammatory Response Index. The primary outcome focused on evaluating the severity of influenza A viral pneumonia. No specific comparator was reported within the study structure provided. Follow up duration was not reported in the available data fields. This absence of longitudinal tracking limits the ability to assess progression over time.

Main results regarding the association between the index and pneumonia severity were not reported in the input JSON. Safety data including adverse events, serious adverse events, and discontinuations were also not reported. Tolerability information was similarly absent from the structured evidence provided. Funding or conflicts of interest were not reported in the source document.

Key limitations include the retrospective nature of the analysis and the lack of reported numerical outcomes. This prevents assessment of statistical significance or clinical magnitude. Practice relevance is limited due to incomplete data reporting. Clinicians should recognize the uncertainty surrounding these specific findings. The evidence remains incomplete for guiding specific therapeutic decisions regarding the Systemic Inflammatory Response Index in this population.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundInfluenza A virus (IAV) pneumonia poses a significant threat to the elderly, often leading to severe outcomes due to age-related immunological decline. Early and accurate assessments of disease severity is critical for improving clinical management and prognosis. The Systemic Inflammatory Response Index (SIRI), which integrates neutrophil, monocyte, and lymphocyte counts, may serve as a novel biomarker to reflect the systemic inflammatory state and predict disease progression in older adults.MethodsA retrospective analysis was conducted involving 160 patients aged 65 years or older who were diagnosed with IAV pneumonia at China Resources Wuhan Iron and Steel General Hospital between December 2024 and March 2025. Patients were categorized into favorable (CURB-65 [confusion, urea, respiratory rate, blood pressure, age ≥ 65 years] score
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.